Search research articles
Contact Us
Filters
Showing results (751-760 of 849) with videos related to
Page
of 85
Sort By:
Hepatology Communications
|
May 16, 2018
Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection
Jacob George, Eduard Burnevich, I-Shyan Sheen, et al.
Trials
|
November 7, 2024
Implementing palliative care in hepatocellular carcinoma ambulatory clinics-study protocol for Accelerated translational research in PRImary liver CAncer (APRICA) randomised controlled palliative care trial
Cameron Gofton, Anna Di Bartolomeo, Rose Boutros, et al.
Cell Reports. Medicine
|
November 2, 2023
Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese
Xi Jia, Erfei Song, Yan Liu, et al.
Ebiomedicine
|
August 13, 2021
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
Mayada Metwally, Ali Bayoumi, Anis Khan, et al.
Gastroenterology
|
May 8, 2018
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
Eduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, et al.
Digestive Diseases and Sciences
|
May 13, 2022
Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort
Paul J Clark, Patricia C Valery, Simone I Strasser, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 1, 2024
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, et al.
Antiviral Research
|
October 13, 2024
Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B
Yijie Tang, Mingzhu Xu, Cong Wang, et al.
Hepatology International
|
June 17, 2025
Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysis
Jing Chen, Dong Ji, Jidong Jia, et al.
Alimentary Pharmacology & Therapeutics
|
December 6, 2021
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach
Jeffrey V Lazarus, Henry E Mark, Massimo Colombo, et al.
Page
of 85
Search research articles
Search
Showing results (751-760 of 849) with videos related to
Sort By:
Page
of 85
Hepatology Communications
|
May 16, 2018
Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection
Jacob George, Eduard Burnevich, I-Shyan Sheen, et al.
Trials
|
November 7, 2024
Implementing palliative care in hepatocellular carcinoma ambulatory clinics-study protocol for Accelerated translational research in PRImary liver CAncer (APRICA) randomised controlled palliative care trial
Cameron Gofton, Anna Di Bartolomeo, Rose Boutros, et al.
Cell Reports. Medicine
|
November 2, 2023
Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese
Xi Jia, Erfei Song, Yan Liu, et al.
Ebiomedicine
|
August 13, 2021
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
Mayada Metwally, Ali Bayoumi, Anis Khan, et al.
Gastroenterology
|
May 8, 2018
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
Eduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, et al.
Digestive Diseases and Sciences
|
May 13, 2022
Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort
Paul J Clark, Patricia C Valery, Simone I Strasser, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 1, 2024
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, et al.
Antiviral Research
|
October 13, 2024
Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B
Yijie Tang, Mingzhu Xu, Cong Wang, et al.
Hepatology International
|
June 17, 2025
Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysis
Jing Chen, Dong Ji, Jidong Jia, et al.
Alimentary Pharmacology & Therapeutics
|
December 6, 2021
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach
Jeffrey V Lazarus, Henry E Mark, Massimo Colombo, et al.
Page
of 85